The acetylcholinesterase inhibitor, ENA 713 (Exelon), attenuates the working memory impairment induced by scopolamine in an operant DNMTP task in rats

Psychopharmacology

Volumn 146, Issue 1, 1999, Pages 10-18

  Ballard, Theresa M ^a,b   McAllister, Kevin H ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Delayed non matching to position task; ENA 713; Exelon; Rat; Scopolamine; Working memory

Indexed keywords

CHOLINESTERASE INHIBITOR; RIVASTIGMINE; SCOPOLAMINE;

ALZHEIMER DISEASE; AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TASK PERFORMANCE; WORKING MEMORY;

ANIMALS; CARBAMATES; CHOLINESTERASE INHIBITORS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MEMORY; NEUROPROTECTIVE AGENTS; PHENYLCARBAMATES; RATS; REACTION TIME; SCOPOLAMINE;

EID: 0032872075     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051082     Document Type: Article

References (36)

1. Aggleton JP, Keith AB, Sahgal A (1991) Both fornix and anterior thalamic, but not mammillary, lesions disrupt delayed non-matching-to-position memory in rats. Behav Brain Res 44: 151-161
2. Anand R, Gharabawi G, Enz A (1996) Efficacy and safety results of the early phase studies with Exelon (ENA 713) in Alzheimer's disease: an overview. J Drug Dev Clin Pract 8:109-116
3. Andrews JS, Jansen JHM, Linders S, Princen A (1994) Effects of disrupting the cholinergic system on short-term spatial memory in rats. Psychopharmacology 115:485-494
4. Ballard TM, Hunter AJ, Bennett GW (1996) Effect of a thyrotrophin-releasing hormone analogue, RX77368, on AMPA-induced septal-hippocampal lesioned rats in an operant delayed non-matching to position test. Psychopharmacology 127:265-275
5. Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, Perl DP, Schmeidler J, Kanof P, Davis KL (1995) Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem 64:749-760
6. Chudasama Y, Muir JL (1997) A behavioural analysis of the delayed non-matching to position task: the effects of scopolamine, lesions of the fornix and of the prelimbic region on mediating behaviours by rats. Psychopharmacology 134:73-82
7. Corey-Bloom J, Anand R, Veach J (1998) A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease. Int J Geriatr Psychopharmacol 1:55-65
8. Davies P, Maloney AJF (1976) Selective loss of central cholinergic neurones in Alzheimer's disease. Lancet ii:1403
9. Dawson GR, Bentley G, Draper F, Rycroft W, Iversen SD, Pagella PG (1991) The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents. Pharmacol Biochem Behav 39:865-871
10. Drachmann DA (1977) Memory and cognitive function in man: does the cholinergic system have a specific role? Neurology 27:783-790
11. Dudchenko P, Sarter M (1992) Behavioral microanalysis of spatial delayed alternation performance: rehearsal through overt behavior, and effects of scopolamine and chlordiazepoxide. Psychopharmacology 107:263-270
12. Dunnett SB (1985) Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats. Psychopharmacology 87:357-363
13. Dunnett SB, Badman F, Rogers DC, Evenden JL, Iversen SD (1988) Cholinergic grafts in the neocortex or hippocampus of aged rats: reduction of delay-dependent deficits in the delayed non-matching to position task. Exp Neurol 102:57-64
14. Enz A, Amstutz R, Hofmann A, Gmelin G, Kelly PH (1989) Pharmacological properties of the preferentially centrally acting acetylcholinesterase inhibitor SDZ ENA 713. In: Kewitz, Thomsen, Bickel (eds) Pharmacological interventions on central cholinergic mechanisms in senile dementia (Alzheimer's disease). Zuckshwerdt Verlag, München, pp 271-277
15. Enz A, Amstutz R, Boddeke H, Gmelin G, Malanowski J (1993) Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease. Prog Brain Res 98:431-438
16. Gottfries CG (1995) Clinical classification of dementias. Arch Gerontol Geriatr 21:1-11
17. Herremans AHJ, Hijzen TH, Welborn PFE, Olivier B, Slangen JL (1996) Effects of infusion of cholinergic drugs into the prefrontal cortex area on delayed matching to position performance in the rat. Brain Res 711:102-111
18. Kalman K, Magloczky E, Janka Z (1995) Disturbed visuo-spatial orientation in the early stage of Alzheimer's dementia. Arch Gerontol Geriatr 21:27-34
19. Kirkby DL, Jones DNC, Higgins GA (1995) Influence of prefeeding and scopolamine upon performance in a delayed matching-to-position task. Behav Brain Res 67:221-227
20. 3 antagonist thioperamide, in models of cognition and cholinergic function. Behav Pharmacol 7:513-525
21. McAlonan GM, Dawson GR, Wilkinson LO, Robbins TW, Everitt BJ (1995) The effects of AMPA-induced lesions of the medial septum and vertical limb nucleus of the diagonal band of Broca on spatial delayed non-matching to sample and spatial learning in the water maze. Eur J Neurosci 7:1034-1049
22. Murray TK, Cross AJ, Green AR (1991) Reversal by tetrahydro-aminoacridine of scopolamine-induced memory and performance deficits in rats. Psychopharmacology 105:134-136
23. Nigawa H, Tanimukai S, Takeda M, Hariguchi S, Nishimura T (1995) Effects of SDZ ENA 713, novel acetylcholinesterase inhibitor, on learning in rats with basal forebrain lesions. Prog Neuro-Psychopharmacol Biol Psychiatry 19:171-186
24. Ohara T, Tanaka K, Fukaya H, Demura N, Iimura A, Seno N (1997a) SDZ ENA 713 facilitates central cholinergic function and ameliorates spatial memory impairment in rats. Behav Brain Res 83:229-233
25. Ohara T, Fukaya H, Tanaka K, Seno N (1997b) Ameliorating effects of SDZ ENA 713 on age-associated decreases in learning performance and brain choline acetyltransferase activity in rats. Brain Res Bull 43:39-42
26. Perry EK, Perry RH, Blessed G, Tomlinson BE (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet i:189
27. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile placques and mental test scores in senile dementia. BMJ 2:1457-1459
28. Robbins TW, Semple J, Kumar R, Truman MI, Shorter J, Ferraro A, Fox B, McKay G, Matthews K (1997) Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia. Psychopharmacology 134:95-106
29. Rösier M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P, Stähelin HB, Hartman R, Gharabawi M (1999) Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ 318:633-638
30. Sahakian BJ, Morris RG, Evenden JL, Heald A, Levy R, Philpot M, Robbins TW (1988) A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 111:695-718
31. Sahgal A, Sahakian BJ, Robbins TW, Wray CJ, Lloyd S, Cook JH, McKeith IG, Disley CA, Boddington S, Edwardson JA (1991) Detection of visual memory and learning deficits in Alzheimer's disease using the Cambridge neuropsychological test automated battery. Dementia 2:150-158
32. Shepherd J, Bill DJ, Dourish CT, Grewal SS, McLenachan A, Stanhope KJ (1996) Effects of the selective angiotensin II receptor antagonists losartan and PD123177 in animal models of anxiety and memory. Psychopharmacology 126:206-218
33. Stanhope KJ, McLenachan AP, Dourish CT (1995) Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists. Psychopharmacology 122:268-280
34. Tanaka K, Ogawa N, Asanuma M, Kondo Y, Mori A (1994) Chronic administration of acetylcholinesterase inhibitor in the senescent rat brain. Neurobiol Aging 15:721-725
35. Thal LJ (1996) Cholinomimetic treatment of Alzheimer's disease. Prog Brain Res 109:299-309
36. Weinstock M, Razin M, Chorev M, Enz A (1994) Pharmacological evaluation of phenyl-carbamates as CNS-selective acetylcholinesterase inhibitors. J Neural Transm (Suppl) 43:219-225